MOLECULERA BIOSCIENCES
Live / Allowed — Notice of allowance issued (as of 06 May 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 Apr 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98526774
- Mark type
- Stylized text
- Filed
- 30 Apr 2024
- Published for opposition
- 11 Mar 2025
- Attorney of record
- David M. Sullivan
Goods and services
- Class 042 — Scientific and technological services: Laboratory testing of materials; Medical and scientific research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Medical research laboratory services; Providing a website featuring educational information in the field of clinical research; Providing information about medical research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Research laboratory analysis services in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment
- Class 044 — Medical, beauty and agricultural services: Antibody testing for medical diagnostic or treatment purposes; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes
Owner
- Moleculera Biosciences, Inc., Oklahoma City, OK, US
- Moleculera Biosciences, Inc., Oklahoma City, OK, US
Prosecution history
- 06 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Nov 2024 — NON-FINAL ACTION E-MAILED
- 19 Nov 2024 — NON-FINAL ACTION WRITTEN
- 14 Nov 2024 — ASSIGNED TO EXAMINER
- 23 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Oct 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS